Dr. Faten Edris
By Faten Edris, OD
Oct. 19, 2026
For many women, vision changes in their 40s and 50s are easy to attribute to aging. The decline of their near vision is an expected part of getting older. But often, their vision changes are not explained by presbyopia alone.
During perimenopause, hormonal fluctuations can affect the ocular surface and tear film, creating symptoms that can be frustrating for patients—and sometimes easy to overlook during an eye exam.
For practitioners, making the hormone connection starts by first knowing what to look for and asking the right questions.
Look for Inconsistencies
One of the biggest clues I look for is instability.
Presbyopia is a normal, progressive loss of near-focusing ability. But hormonal changes can even make their myopia feel different. A patient may see clearly in the morning and struggle by evening, or her vision may fluctuate from day to day.
I have seen women who have worn the same glasses for years suddenly feel that their vision correction “doesn’t work” or their tried-and-true contact lenses are now uncomfortable. Their instinct is to blame the prescription, but sometimes there is no meaningful change in their refractive error. When the exam doesn’t seem to match the complaint, I look more closely at the ocular surface, and what I find can completely change the conversation.
Ask the Hormone Questions
Getty Images
Hormonal changes should be part of the routine history for women in this stage of life. It doesn’t have to be complicated. I might simply ask, “Are you experiencing symptoms of perimenopause or menopause?” or “Does your vision change throughout the day, or is it pretty consistent?”
Other simple questions can also provide valuable insight:
- Are your eyes dry, gritty or tired by the afternoon?
- Have you noticed any difference in the comfort of your contact lenses?
- How is your sleep?
When this conversation is initiated the doctor, it is part of routine medical care rather than something uncomfortable or personal. It also tells the patient that what she’s experiencing is worth discussing—and normal.
Think Beyond the Prescription
When I suspect hormonal changes are contributing to a patient’s symptoms, I start by validating what she’s experiencing. Many of these women have already been told that their eyes look fine. I want them to understand that what they’re describing is real, and it’s common at this stage of life.
Then, I take a thorough history and evaluate the tear film, meibomian glands, corneal staining, refraction and binocular function. If the ocular surface is unstable, I don’t want to immediately turn to a prescription change. Any lens can disappoint when the surface underneath isn’t healthy.
Treatment may include an at-home regimen or in-office therapies for meibomian gland dysfunction. I also believe in appropriate co-management with a patient’s other healthcare providers when systemic or hormonal factors may be contributing.
It is important to recognize when the eye is giving us information about the whole patient.
Focus on Lifestyle, Not Age
For many women, perimenopause coincides with another vision change: the onset or progression of presbyopia. This overlap makes it even more important to understand what is driving a patient’s symptoms and what she needs from her vision throughout the day.
When I talk with patients about presbyopia, I don’t lead with age. I talk about what they need their vision to do.
Many women in this stage of life are at peak professional demand. They’re moving between presentations, laptops, phones, reading and driving, requiring clear vision at multiple distances. They may be frustrated not only because near vision is changing, but because they suddenly don’t have the same visual flexibility that they used to. And for some, the idea of constantly reaching for reading glasses doesn’t fit how they want to move through their day. They want vision correction that keeps up with their lives.
That is where multifocal contact lenses enter the conversation. For many patients, they provide visual acuity across all distances while maintaining freedom from glasses. I frame them as a technology designed to match her lifestyle, rather than as a concession to aging.
At the same time, expectations matter. If a perimenopausal patient’s vision is fluctuating due to tear film instability or ocular surface disease, even a well-fit multifocal lens may not perform consistently. Taking the time to address the ocular surface can put us in a much better position for success with multifocals.
Connect the Dots
For many women, the most valuable thing we can do is help them understand why their vision suddenly feels different.
A patient may come into the office thinking her prescription has changed, when in reality several things may be happening at once: her near vision is changing with presbyopia, her ocular surface may be less stable, and hormonal fluctuations may be affecting the consistency and comfort of her vision.
Helping her connect those dots can be reassuring. And it can lead to better care. Rather than dismissing these changes as simply part of getting older, we have an opportunity to ask the right questions, investigate what is driving her symptoms, and identify solutions that support both her visual needs and her quality of life.
Read more from The Aging Eye here.
Faten Edris, OD, is a Florida optometrist and the owner of Blinking Owl Eyecare, a multi-location practice with a strong emphasis on dry eye and ocular surface care, including in-office IPL and radiofrequency treatments. She serves on the Target Optical Advisory Board, is a speaker for CooperVision and sits on the advisory board of a Miami medical concierge practice specializing in longevity and wellness.
